Matches in Nanopublications for { ?s ?p "[The highly immunogenic human tumor antigen NY-ESO-1 (ESO) is a target of choice for anti-cancer immune therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP222292.RA1bOEyszAoyzirb8wvKKRmnETiMIz2hIynCKWxRjWxgY130_assertion description "[The highly immunogenic human tumor antigen NY-ESO-1 (ESO) is a target of choice for anti-cancer immune therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP222292.RA1bOEyszAoyzirb8wvKKRmnETiMIz2hIynCKWxRjWxgY130_provenance.
- NP981203.RACp4BhIsjvwLercZ8NSXB84XWI7dkcMJdFSeX41qVCbU130_assertion description "[The highly immunogenic human tumor antigen NY-ESO-1 (ESO) is a target of choice for anti-cancer immune therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP981203.RACp4BhIsjvwLercZ8NSXB84XWI7dkcMJdFSeX41qVCbU130_provenance.
- NP334330.RAQ14U5tGzO6zrq0CZQsegpgSauDfqCa9GDCSL5mf45U8130_assertion description "[The highly immunogenic human tumor antigen NY-ESO-1 (ESO) is a target of choice for anti-cancer immune therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP334330.RAQ14U5tGzO6zrq0CZQsegpgSauDfqCa9GDCSL5mf45U8130_provenance.